Long-term safety of satralizumab in neuromyelitis optica spectrum disorder: results from the open-label extension periods of SAkuraSky and SAkuraStar

被引：0
|
作者：
Greenberg, B. M. [1 ]
de Seze, J. [2 ]
Saiz, A. [3 ,4 ]
Yamamura, T. [5 ]
Yeaman, M. [6 ]
Marcillat, C. [7 ]
Kou, X. [7 ]
Weber, K. [7 ]
Blondeau, K. [7 ]
Weinshenker, B. G. [8 ]
Patti, F. [9 ,10 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] Hop Hautepierre, Strasbourg, France
[3] Hosp Clin Barcelona, Serv Neurol, Barcelona, Spain
[4] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain
[5] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Tokyo, Japan
[6] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA
[7] F Hoffmann La Roche Ltd, Basel, Switzerland
[8] Mayo Clin, Rochester, MN USA
[9] Univ Catania, Dept Med & Surg Sci & Adv Technol GF Ingrassia, Catania, Italy
[10] Multiple Sclerosis Ctr AOU Policlin G Rodolico Sa, Catania, Italy
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P023
引用
收藏
页码：147 / 148
页数：2
相关论文
共 50 条
  • [21] Pegloticase Long-Term Safety: Data From the Open-Label Extension Trial.
    Becker, Michael A.
    Baraf, Herbert S. B.
    Yood, Robert A.
    Dillon, Aileen M.
    Vazquez-Mellado, Janitzia
    Ottery, Faith D.
    Khanna, Dinesh
    Sundy, John S.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S69 - S70
  • [22] Neuromyelitis optica and neuromyelitis optica spectrum disorder: Natural history and long-term outcome, an Indian experience
    Jagtap, Sujit Abajirao
    Mandliya, Alok
    Sarada, C.
    Nair, M. D.
    JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE, 2015, 6 (03) : 331 - 335
  • [23] Long-Term Efficacy and Safety of Etrasimod for Ulcerative Colitis: Results From the Open-Label Extension of the OASIS Study
    Chiorean, Michael
    Vermeire, Severine
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Cabell, Chris H.
    Naik, Snehal U.
    Klassen, Preston
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S445 - S446
  • [24] Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial
    Cutler, Andrew J.
    Kalali, Amir H.
    Mattingly, Greg W.
    Kunovac, Jelena
    Meng, Xiangyi
    CNS SPECTRUMS, 2013, 18 (01) : 43 - 54
  • [25] Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study
    Vermeire, Severine
    Chiorean, Michael
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Zhang, Jinkun
    Sands, Bruce E.
    Lazin, Krisztina
    Klassen, Preston
    Naik, Snehal U.
    Cabell, Christopher H.
    Sandborn, William J.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (06): : 950 - 959
  • [26] Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study
    Shaygannejad, V.
    Fayyazi, E.
    Badihian, S.
    Mirmosayyeb, O.
    Manouchehri, N.
    Ashtari, F.
    Asgari, N.
    JOURNAL OF NEUROLOGY, 2019, 266 (03) : 642 - 650
  • [27] Long-term efficacy and safety of eculizumab in aqp4+neuromyelitis optica spectrum disorder
    Wingerchuk, D.
    Berthele, A.
    Fujihara, K.
    Oreja-Guevara, C.
    Kim, H. J.
    Levy, M.
    Nakashima, I.
    Palace, J.
    Shang, S.
    Yountz, M.
    Miller, L.
    Pittock, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 465 - 465
  • [28] Long-term tolerability, safety and efficacy of rituximab in neuromyelitis optica spectrum disorder: a prospective study
    V. Shaygannejad
    E. Fayyazi
    S. Badihian
    O. Mirmosayyeb
    N. Manouchehri
    F. Ashtari
    N. Asgari
    Journal of Neurology, 2019, 266 : 642 - 650
  • [29] Efficacy and safety of satralizumab monotherapy for relapse prevention in neuromyelitis optica spectrum disorder (NMOSD): Results from SAkuraStar, a double-blind placebo-controlled phase 3 clinical study
    Traboulsee, A.
    Greenberg, B.
    Bennett, J. L.
    Szczechowski, L.
    Fox, E.
    Shkrobot, S.
    Yamamura, T.
    Terada, Y.
    Kawata, Y.
    Wright, P.
    von Budingen, H. C.
    Klingelschmitt, G.
    Gianella-Borradori, A.
    Weinshenker, B. G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [30] Long-term Efficacy and Safety of Rituximab in Neuromyelitis Optica Spectrum Disorder and MOG Antibody Disease
    Barreras, P.
    Vasileiou, E.
    Filippatou, A.
    Fitzgerald, K.
    Levy, M.
    Mowry, E. M.
    Calabresi, P.
    Sotirchos, E.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 145 - 146
12345